Shares of struggling drug maker Affymax (Nasdaq: AFFY) are back under pressure on Tuesday following the release of the company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE